Labeling process and quality control results of 225Ac-PSMA-617 for targeted alpha particle therapy for metastatic prostate cancer
R Shukurov, M Veliyev, Z Dadashov, J İsayev… - 2019 - Soc Nuclear Med
1611 Objectives: Prostate cancer is one of the most spread form in cancer patients.
Therefore, interest treatment of prostate cancer 225Ac-PSMA-617 for PSMA-Targeted a-Radiation …
Therefore, interest treatment of prostate cancer 225Ac-PSMA-617 for PSMA-Targeted a-Radiation …
Tandem therapy versus single agent 177Lu-PSMA and 225Ac-PSMA therapy of advanced stage metastatic castration resistant prostate carcinoma: Clinical trial from …
F Novruzov, G Aliyeva, R Shukurov, S Novruzova… - 2022 - Soc Nuclear Med
2548 Introduction: Prostate-specific membrane antigen (PSMA) is a unique target in
metastatic castration resistant prostate carcinoma (mCRPC) patients. Although remarkable …
metastatic castration resistant prostate carcinoma (mCRPC) patients. Although remarkable …
Head to head comparison of 68Ga-FAPI-46 PET/CT and 18-FDG PET/CT in breast carcinoma staging: a clinical trial update from Azerbaijan
2372 Introduction: Breast cancer is the most frequently diagnosed cancer and is the leading
cause of cancer death in women worldwide. Accurate clinical staging is important for …
cause of cancer death in women worldwide. Accurate clinical staging is important for …
The impact of PSMA based PET-CT imaging in treatment management of prostate cancer: Results of 335 patients from Azerbaijan Republic
…, V İsmailov, R Sholan, E Dashdamirli, R Shukurov… - 2023 - Soc Nuclear Med
P1550 Introduction: Prostate cancer is the most common malignancy among men and the
third leading cause of cancer death in economically developed countries. The mortality rate …
third leading cause of cancer death in economically developed countries. The mortality rate …
The Role of 18F-PSMA-1007 PET-CT Imaging In Treatment Management Of Malignant Brain Tumors: Pilot Study From Azerbaijan
…, G Aliyeva, N Aliyeva, Z Dadashov, R Shukurov… - 2022 - Soc Nuclear Med
3116 Introduction: Prostate-specific membrane antigen-PSMA (also known as glutamate
carboxypeptidase II) is overexpressed in prostate cancer epithelium, making it a target for …
carboxypeptidase II) is overexpressed in prostate cancer epithelium, making it a target for …
[CITATION][C] New approach to production and quality control of 16α-[18F] fluoroestradiol ([18F] FES: The effective functional molecular imaging probe for positive …
Z Dadashov, R Shukurov, M Valiyev, K Eryilmaz… - 2019 - EANM'19
[CITATION][C] Application of production and quality control procedures of 18F-PSMA-1007: dominant in diagnosis of prostate cancer, through Synthera V2
R Shukurov, M Balashov, Z Dadashov, M Valiyev… - 2019 - EANM'19
[CITATION][C] Simultaneous production 18F-FDG and other 18F based (18F-NaF, 18F-FES, 18F-PSMA 1007, 18F-FET) radiopharmaceutical drug by a single run of …
Z Dadashov, M Valiyev, R Shukurov, M Balashov… - 2019 - EANM'19